Digital Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Device Type (Smartphone, Tablets, Others), Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

Global Digital Vaccine Market is projected to witness impressive growth during the forecast period. Global digital vaccine market stood at USD 1534.07 million in 2022 and is expected to register a CAGR of 10.66% and reach USD 2779.10 million by 2028. The goal of Digital Vaccine is to change behavior patterns and enhance both mental and physical health by employing neurocognitive training and nudging tactics. A digital vaccination is a tool that trains the brain and encourages good habits using a variety of digital technologies, such as virtual reality, smartphone apps, and artificial intelligence. Moreover, digital vaccines are cutting-edge technologies that can aid individuals in enhancing their mental health and encouraging positive behavior. They are affordable, simple to use, and adaptable to different demands. Also, they have the ability to help where it is most needed and reach a huge audience. Digital vaccinations hold great promise for enhancing mental health and encouraging good conduct in people. These vaccinations have the ability to assist people in forming healthier behaviors and leading better, more meaningful lives by combining neurocognitive training and nudging strategies. The potential for digital vaccines to promote positive change is enormous and exciting as digital technologies continue to develop.

Digital vaccines have undergone a revolution as a result of the booming healthcare IT market and the development of cutting-edge ideas like the Internet of Things (IoT), wearable technology, metaverse platforms, and augmented reality (AR/VR). These innovations are allowing for much more frequent behavioral interventions to treat a wide range of diseases and phobias. For instance, the National Center for Telehealth and Technology (T2) of the US Department of Defense has created a computer application Virtual PTSD Experience which is based on the internationally populated virtual world called second life. In this virtual reality video game, military soldiers can create a virtual avatar to play through scenarios that are realistic and help with mental health issues. Further,

Growing Prevalence of Diseases

Noncommunicable diseases (NCDs) impact people from all age groups, geographical areas, and nations. Although these illnesses are frequently linked to older age groups, statistics show that 17 million deaths from Non-communicable diseases (NCDs) happen before the age of 70. According to estimates, 86% of these early fatalities take place in low- and middle-income nations, owing to a lack of awareness and availability of digital technologies. As per World Health Organization (WHO), noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally which is expected to boost the demand of digital vaccines throughout the forecast period.

For instance, cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).

Focus on Personalized Medicine

One of the most promising methods for combating diseases especially in case of the diseases lacking any kind of potential treatment, is precision medicine, often known as personalized medicine. People, families, and entire civilizations suffer greatly as a result of cancer, neurological illnesses, and unusual genetic abnormalities. Due to greater patient response and the maximum safety margin to assure better patient care, personalized medicines have recently grown in favor among healthcare professionals. The potential for improved healthcare, even at a cheaper cost, is shown by personalized therapeutics. The patient can benefit from an early diagnosis, risk management, and the best possible care. Moreover, an increasing tendency that aimed to provide patients with personalized care gave rise to personalized medicine which led the growth of the digital vaccine market. Further, the use of digital biomarkers to define more exact outcome measures and clinical research objectives is becoming more and more important. They can involve voice-recorded mood and disease progression, cognitive exams performed as games on tablets, and actigraphy. Hence, rising awareness and focus on personalized medicines drive the growth of digital vaccines throughout the forecast period.

Increase in Clinical Trials and Patents of Digital Vaccine

For instance, Vydiant Inc. filed a patent on 25 March 2022; titled “A Digital Vaccine System, Method and Device”.

Data Privacy and Security Concerns to Hamper the Growth of the Market

Confidentiality of patient data is stored in digital vaccine management systems, so protecting the privacy and security of this information is of utmost importance. Hacking, data breaches, and unauthorized access to this sensitive information are worries. This is a significant worry that prevents individuals from adopting many digital vaccine solutions. Furthermore, the lack of consistent internet and electronic device connectivity makes it challenging to apply digital vaccine management systems efficiently in many parts of the world. Also, a lack of knowledge about cutting-edge solutions like digital vaccinations among the populace, particularly in developing and emerging nations, may hinder the expansion of the global market for digital vaccines.

Market Segmentation

The Global Digital Vaccine Market is segmented based on

Market players

FriendsLearn, Inc., Klein Buendel, Inc, Evidation Health, Inc., Atos SE, oVRcome.